YOLT-204

DRUG3 trials

Sponsors

First Affiliated Hospital of Guangxi Medical University, Guangzhou Women and Children's Medical Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Conditions

HemoglobinopathiesHemoglobinopathies (Transfusion-dependent β-thalassemia and Sickle Cell Disease)Transfusion Dependent Beta Thalassemia

Early Phase 1

A Pilot Study on the Safety and Efficacy of YOLT-204 for Transfusion-Dependent Beta-Thalassemia

Not yet recruitingNCT06678165

First Affiliated Hospital of Guangxi Medical UniversityTransfusion Dependent Beta Thalassemia

Start: 2024-12-31End: 2026-06-01Target: 3Updated: 2024-11-07

YOLT-204 in Patients With Hemoglobinopathies

Not yet recruitingNCT07190001

Guangzhou Women and Children's Medical CenterHemoglobinopathies (Transfusion-dependent β-thalassemia and Sickle Cell Disease)

Start: 2025-09-30End: 2027-04-30Target: 18Updated: 2025-09-24

Unknown Phase

A Clinical Exploratory Study of YOLT-204 in the Treatment of Hemoglobinopathies

Not yet recruitingNCT07774351

Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyHemoglobinopathies

Start: 2026-09-30End: 2028-04-01Target: 30Updated: 2026-08-19